Total Payments
$11,027
2024 Payments
$2,301
Companies
40
Transactions
528
Medicare Patients
2,762
Medicare Billing
$317,401
Payment Breakdown by Category
Food & Beverage$11,027 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,027 | 528 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,684 | 135 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,489 | 75 | $0 (2024) |
| Janssen Biotech, Inc. | $894.17 | 35 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $860.40 | 45 | $0 (2024) |
| PFIZER INC. | $785.48 | 36 | $0 (2024) |
| Celgene Corporation | $526.98 | 26 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $392.68 | 18 | $0 (2017) |
| GENZYME CORPORATION | $360.86 | 13 | $0 (2024) |
| Gilead Sciences, Inc. | $327.43 | 15 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $270.91 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,301 | 89 | ABBVIE INC. ($558.13) |
| 2023 | $2,368 | 98 | ABBVIE INC. ($635.54) |
| 2022 | $1,042 | 47 | ABBVIE INC. ($391.41) |
| 2021 | $274.24 | 12 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($127.98) |
| 2020 | $279.63 | 16 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($109.68) |
| 2019 | $1,439 | 84 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($292.96) |
| 2018 | $1,790 | 99 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($477.37) |
| 2017 | $1,533 | 83 | Valeant Pharmaceuticals North America LLC ($392.68) |
All Payment Transactions
528 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.28 | General |
| 12/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.48 | General |
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/11/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/09/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: LIVER DISEASE | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.68 | General |
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $120.59 | General |
| Category: Immunology | ||||||
| 11/07/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.63 | General |
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Stryker Corporation | NEPTUNE (Device) | Food and Beverage | In-kind items and services | $68.59 | General |
| Category: SURGICAL | ||||||
| 10/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Gastroenterology | ||||||
| 09/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.23 | General |
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.62 | General |
| Category: Neuroscience | ||||||
| 09/12/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $143.98 | General |
| Category: Immunology | ||||||
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 761 | 882 | $431,170 | $84,210 |
| 2022 | 12 | 1,017 | 1,378 | $577,602 | $118,616 |
| 2021 | 10 | 604 | 668 | $351,936 | $70,432 |
| 2020 | 9 | 380 | 436 | $243,094 | $44,142 |
Total Patients
2,762
Total Services
3,364
Medicare Billing
$317,401
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 402 | 492 | $147,600 | $32,254 | 21.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 62 | 62 | $89,900 | $13,927 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 96 | $31,200 | $10,473 | 33.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 37 | 39 | $27,690 | $7,297 | 26.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 46 | 48 | $49,200 | $5,559 | 11.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 41 | 41 | $41,000 | $4,916 | 12.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $9,500 | $2,510 | 26.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $15,200 | $2,393 | 15.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 32 | $8,000 | $2,144 | 26.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $4,200 | $1,321 | 31.5% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 13 | 13 | $3,900 | $793.64 | 20.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,780 | $622.78 | 16.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 683 | 1,013 | $303,900 | $69,836 | 23.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 58 | 58 | $41,180 | $11,396 | 27.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 47 | 49 | $71,050 | $10,809 | 15.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 48 | 48 | $48,000 | $6,087 | 12.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 45 | 46 | $47,150 | $5,168 | 11.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 16 | 16 | $10,752 | $3,207 | 29.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 51 | $12,750 | $3,099 | 24.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 38 | 38 | $11,970 | $3,022 | 25.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $14,250 | $2,309 | 16.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $6,650 | $2,188 | 32.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $7,150 | $1,121 | 15.7% |
| 91200 | Measurement of liver stiffness | Office | 2022 | 14 | 14 | $2,800 | $374.64 | 13.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 288 | 342 | $102,600 | $26,733 | 26.1% |
About Dr. Peter Krims, M.D
Dr. Peter Krims, M.D is a Gastroenterology healthcare provider based in Acton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1962400366.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Krims, M.D has received a total of $11,027 in payments from pharmaceutical and medical device companies, with $2,301 received in 2024. These payments were reported across 528 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($11,027).
As a Medicare-enrolled provider, Krims has provided services to 2,762 Medicare beneficiaries, totaling 3,364 services with total Medicare billing of $317,401. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Acton, MA
- Active Since 07/09/2005
- Last Updated 08/15/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1962400366
Products in Payments
- XIFAXAN (Drug) $997.26
- STELARA (Biological) $826.00
- RINVOQ (Biological) $759.25
- Humira (Biological) $718.16
- ZEPOSIA (Drug) $607.76
- XELJANZ (Drug) $593.91
- DUPIXENT (Biological) $426.62
- ENTYVIO (Biological) $376.45
- Entyvio (Biological) $319.13
- SKYRIZI (Biological) $312.24
- TREMFYA (Drug) $290.96
- LINZESS (Drug) $283.94
- MOVIPREP (Drug) $277.51
- CREON (Drug) $250.46
- RELISTOR (Drug) $195.72
- Cimzia (Drug) $185.21
- Trulance (Drug) $181.16
- VOQUEZNA (Drug) $161.74
- Creon (Drug) $155.74
- UCERIS TABLETS (Drug) $146.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Acton
Dr. Raj Devarajan, Md, MD
Gastroenterology — Payments: $12,522
Gastroenterology $12,522
Dr. Lauren Bleich, Md/Mph, MD/MPH
Gastroenterology — Payments: $11,542
Gastroenterology $11,542
Leah Creahan, Md, MD
Gastroenterology — Payments: $2,635
Gastroenterology $2,635
Gail Herzig, Md, MD
Gastroenterology — Payments: $2,534
Gastroenterology $2,534
Dr. Abhijeet Kashyap, Md, MD
Gastroenterology — Payments: $2,402
Gastroenterology $2,402